Novo Nordisk A/S (NVO)
Novo Nordisk A/S EPS
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.1 | $0.2 | $0.2 | $0.2 | $0.3 | $0.3 | $0.4 | $0.6 | $1.3 | $0.8 | $0.9 | $1.0 | $1.1 | $1.2 | $0.6 | $0.6 | $1.4 | $1.7 | $1.7 | $1.4 |
Novo Nordisk A/S (NVO) EPS comparison analysis
NVO key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Novo Nordisk A/S's EPS?
As of today, Novo Nordisk A/S's last 12-month EPS is $3.1, based on the financial report for Sep 30, 2024 (Q3 2024).
2) What is Novo Nordisk A/S's EPS growth rate?
Over the last year, Novo Nordisk A/S's EPS growth was (24.3%). The average annual EPS growth rates for Novo Nordisk A/S have been 2.3% over the past three years, 4.7% over the past five years.
3) Is Novo Nordisk A/S's EPS growth rate Good?
Over the last year, Novo Nordisk A/S's EPS growth was (24.3%), which is lower than industry growth of (0.2%). It indicates that Novo Nordisk A/S's EPS growth is Bad.